$ 235.91 <%= Resources.Global.txtDown %>
Updated 23/06/2019
Change % -1.33% Stock price decreasing
Change -3.18 Stock price decreasing
Volume 1,089,609
High $ 241.31
Low $ 235.33
Open $ 238.70
ISIN
Prev close $ 239.09
# of shares 193.89M
Market cap 45,741M USD
Intraday

Market closed
Biogen Inc
Market is closed, opens at 14:30
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  235.91 1.2% Stock price increasing 3.9% Stock price increasing 7.1% Stock price increasing -15.3% Stock price decreasing -19.3% Stock price decreasing
Powered by TradingView

News about Biogen Inc

  • English
  • Regulatory news

Related

Latest 1 week 1 month 3 months 6 months 1 year
YTD
 
Competitors Open
 
Abbott Laboratories 84.71 1.5% Stock price increasing 10.0% Stock price increasing 8.3% Stock price increasing 29.2% Stock price increasing 39.4% Stock price increasing 17.1% Stock price increasing
 
Bristol-Myers Squibb Company 45.68 -4.4% Stock price decreasing -2.4% Stock price decreasing -3.8% Stock price decreasing -6.3% Stock price decreasing -16.4% Stock price decreasing -12.1% Stock price decreasing
 
Johnson & Johnson 143.06 2.0% Stock price increasing 3.0% Stock price increasing 4.7% Stock price increasing 16.5% Stock price increasing 16.7% Stock price increasing 10.9% Stock price increasing
 
Pfizer Inc 43.76 1.6% Stock price increasing 4.3% Stock price increasing 4.5% Stock price increasing 7.9% Stock price increasing 20.3% Stock price increasing 0.3% Stock price increasing
 
Amgen Inc 184.83 1.8% Stock price increasing 7.9% Stock price increasing -0.9% Stock price decreasing 3.6% Stock price increasing -0.3% Stock price decreasing -5.1% Stock price decreasing
 
Novartis AG 92.80 1.6% Stock price increasing 6.0% Stock price increasing -0.5% Stock price decreasing 12.5% Stock price increasing 25.4% Stock price increasing 8.1% Stock price increasing
 
GlaxoSmithKline PLC 40.59 0.9% Stock price increasing 1.0% Stock price increasing -1.5% Stock price decreasing 9.0% Stock price increasing 1.7% Stock price increasing 6.2% Stock price increasing
 
UCB 72.40 1.7% Stock price increasing 4.5% Stock price increasing -3.9% Stock price decreasing 0.9% Stock price increasing 8.9% Stock price increasing 1.5% Stock price increasing
 
Roche Hldg Sp.Adr 1/8 30.99 1.0% Stock price increasing 3.3% Stock price increasing 5.2% Stock price increasing 18.2% Stock price increasing 33.0% Stock price increasing 20.0% Stock price increasing
 
Sanofi SA ADR 1/2/EO 2 38.80 0.5% Stock price increasing 4.9% Stock price increasing 0.5% Stock price increasing 4.3% Stock price increasing 12.8% Stock price increasing 6.0% Stock price increasing
 
Teva Pharmaceutical Industries.. 8.250 -1.3% Stock price decreasing -24.1% Stock price decreasing -48.1% Stock price decreasing -43.5% Stock price decreasing -65.0% Stock price decreasing -46.5% Stock price decreasing

Company profile

Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are marketed via a collaboration with Roche. Biogen also markets novel MS drugs Tysabri and Tecfidera. In Japan, Biogen's MS portfolio is co-promoted by Eisai. Hemophilia therapies Eloctate and Alprolix (partnered with SOBI) were spun off as part of Bioverativ in 2017. Biogen has several drug candidates in phase 3 trials in neurology and neurodegenerative diseases and has launched Spinraza with partner Ionis.

Peers

Instruments Last Change  
Abbott Labor.. 84.71 -0.3% Stock price decreasing
Bristol-Myer.. 45.68 -7.4% Stock price decreasing
Johnson & Jo.. 143.06 0.7% Stock price increasing
Pfizer Inc 43.76 0.2% Stock price increasing
Amgen Inc 184.83 -1.2% Stock price decreasing
100,60,52,56,61,44,38,33,21,0
Novartis AG 92.80 0.3% Stock price increasing
GlaxoSmithKl.. 40.59 0.8% Stock price increasing
UCB 72.40 0.6% Stock price increasing
Roche Hldg S.. 30.99 -0.8% Stock price decreasing
0,0,0,0,0,0,0,0,0,0
Sanofi SA AD.. 38.80 -1.0% Stock price decreasing
0,0,0,0,0,100,100,100,100,100
Teva Pharmac.. 8.250 -2.4% Stock price decreasing

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
25 June 2019 03:28:51
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190527.1 - EUROWEB5 - 2019-06-25 04:28:51 - 2019-06-25 03:28:51 - 1000 - Website: OKAY